Literature DB >> 15184290

Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging.

Marc Sirol1, Vitalii V Itskovich, Venkatesh Mani, Juan Gilberto S Aguinaldo, John T Fallon, Bernd Misselwitz, Hanns-Joachim Weinmann, Valentin Fuster, Jean-François Toussaint, Zahi A Fayad.   

Abstract

BACKGROUND: MRI of specific components in atherosclerotic plaque may provide information on plaque stability and its potential to rupture. We evaluated gadofluorine in atherosclerotic rabbits using a new MR sequence that allows plaque detection within 1 hour after injection and assessed enhancement in lipid-rich and non-lipid-rich plaques. METHODS AND
RESULTS: Twelve rabbits with aortic plaque and 6 controls underwent MRI before and up to 24 hours after gadofluorine injection (50 micromol/kg). Two T1-weighted, segmented gradient-echo sequences (TFL) were compared to enhance vessel wall delineation after injection: (1) an inversion-recovery prepulse (IR-TFL) or (2) a combination of inversion-recovery and diffusion-based flow suppression prepulses (IR-DIFF-TFL). With the use of IR-TFL at 1 hour after injection, the vessel wall was not delineated because of poor flow suppression; at 24 hours after injection, the enhancement was 37% (P<0.01). IR-DIFF-TFL showed significant enhancement after versus before contrast (1 hour: 164% [P<0.005]; 24 hours: 207% [P<0.001]). At 1 hour and 24 hours after injection, the contrast-to-noise ratio was higher with the use of IR-DIFF-TFL than with IR-TFL (1 hour: 13.0+/-7.7 versus -19.8+/-10.3 [P<0.001]; 24 hours: 15.2+/-5.9 versus 11.4+/-8.9, respectively [P=0.052]). There was no enhancement in the vessel wall after gadofluorine injection in the control group. A strong correlation was found (r2=0.87; P<0.001) between the lipid-rich areas in histological sections and signal intensity in corresponding MR images. This suggests a high affinity of gadofluorine for lipid-rich plaques.
CONCLUSIONS: Gadofluorine-enhanced MRI improves atherosclerotic plaque detection. The IR-DIFF-TFL method allows early detection of atherosclerotic plaque within 1 hour after gadofluorine injection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184290     DOI: 10.1161/01.CIR.0000129310.17277.E7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

2.  Preliminary ex vivo 3D microscopy of coronary arteries using a standard 1.5 T MRI scanner and a superconducting RF coil.

Authors:  M Poirier-Quinot; J-C Ginefri; F Ledru; P Fornes; L Darrasse
Journal:  MAGMA       Date:  2005-02-11       Impact factor: 2.310

3.  Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease.

Authors:  L M Mitsumori; J L Ricks; M E Rosenfeld; U P Schmiedl; C Yuan
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

4.  Identification of interleukin-2 for imaging atherosclerotic inflammation.

Authors:  Zahi A Fayad; Vardan Amirbekian; Jean-François Toussaint; Valentin Fuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02       Impact factor: 9.236

5.  High-resolution 3D arteriography of chronic total peripheral occlusions using a T1-W turbo spin-echo sequence with inner-volume imaging.

Authors:  Smita Sampath; Amish N Raval; Robert J Lederman; Elliot R McVeigh
Journal:  Magn Reson Med       Date:  2007-01       Impact factor: 4.668

Review 6.  What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease?

Authors:  Benjamin J W Chow; John P Veinot
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

7.  Cell labeling with the positive MR contrast agent Gadofluorine M.

Authors:  Tobias D Henning; Olaf Saborowski; Daniel Golovko; Sophie Boddington; Jan S Bauer; Yanjun Fu; Reinhard Meier; Hubertus Pietsch; Barbara Sennino; Donald M McDonald; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

Review 8.  MRI versus CT for the detection of coronary artery disease: current state and future promises.

Authors:  Bernhard L Gerber
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

Review 9.  MR-optical imaging of cardiovascular molecular targets.

Authors:  Matthias Nahrendorf; David E Sosnovik; Ralph Weissleder
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

10.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.